Cargando…

Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer

Detalles Bibliográficos
Autores principales: Allen, Joshua E., Gallant, Jean-Nicolas, Dicker, David T., Amin, Shantu, Irby, Rosalyn B., Sharma, Arun K., El-Deiry, Wafik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820801/
http://dx.doi.org/10.1371/annotation/aaa12360-0c90-42c3-bc43-d00022b68b81
_version_ 1782290206129389568
author Allen, Joshua E.
Gallant, Jean-Nicolas
Dicker, David T.
Amin, Shantu
Irby, Rosalyn B.
Sharma, Arun K.
El-Deiry, Wafik S.
author_facet Allen, Joshua E.
Gallant, Jean-Nicolas
Dicker, David T.
Amin, Shantu
Irby, Rosalyn B.
Sharma, Arun K.
El-Deiry, Wafik S.
author_sort Allen, Joshua E.
collection PubMed
description
format Online
Article
Text
id pubmed-3820801
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38208012013-11-15 Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer Allen, Joshua E. Gallant, Jean-Nicolas Dicker, David T. Amin, Shantu Irby, Rosalyn B. Sharma, Arun K. El-Deiry, Wafik S. PLoS One Correction Public Library of Science 2013-11-07 /pmc/articles/PMC3820801/ http://dx.doi.org/10.1371/annotation/aaa12360-0c90-42c3-bc43-d00022b68b81 Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Allen, Joshua E.
Gallant, Jean-Nicolas
Dicker, David T.
Amin, Shantu
Irby, Rosalyn B.
Sharma, Arun K.
El-Deiry, Wafik S.
Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title_full Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title_fullStr Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title_full_unstemmed Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title_short Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
title_sort correction: the akt inhibitor isc-4 synergizes with cetuximab in 5-fu-resistant colon cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820801/
http://dx.doi.org/10.1371/annotation/aaa12360-0c90-42c3-bc43-d00022b68b81
work_keys_str_mv AT allenjoshuae correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT gallantjeannicolas correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT dickerdavidt correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT aminshantu correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT irbyrosalynb correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT sharmaarunk correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer
AT eldeirywafiks correctiontheaktinhibitorisc4synergizeswithcetuximabin5furesistantcoloncancer